- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2022 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma

CITE Title : Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma Personal Author(s) : Pritchard, Jessica E.;Wilson, Lauren E.;Miller, Samuel M.;Greiner, Melissa A.;Cohen, Harvey Jay;Kaye, Deborah R.;Zhang, Tian;Dinan, Michaela A.; Published Date : 8 2022;8-2022; Source : J Am Geriatr Soc. 70(8):2330-2343 URL : https://stacks.cdc.gov/view/cdc/120414 Pritchard, Jessica E. et al. (2022). Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma. 70(8). Pritchard, Jessica E. et al. "Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma" 70, no. 8 (2022) Pritchard, Jessica E. et al. "Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma" vol. 70, no. 8, 2022 Export RIS Citation Information.

:

Pritchard, Jessica E. ;

Wilson, Lauren E.

8 2022 | J Am Geriatr Soc. 70(8):2330-2343

:

BackgroundKidney cancer is the fastest-growing cancer diagnosis in the developed world. About 16% of new cases are stage IV, which has a low five-year...

To see more results, try removing search filters or changing the search terms